|
- Auto-BMD Patient - Livelong
AutoBMD™ enables your doctor to take advantage of CT scans ordered for other purposes and measure your bone density
- Bone Mineral Density Measurement | HeartLung. AI
HeartLung AI has received FDA approval for their AutoBMD solution and is pending 510k approval for AutoCAC and AutoChamber that aims to enhance traditional coronary artery calcium scoring Their AutoChamber tool achieved FDA Breakthrough Device Designation
- HeartLung Receives FDA “Breakthrough” Marketing Authorization for First . . .
The FDA Breakthrough Device designation for AutoChamber™ follows the FDA’s recent clearance of HeartLung’s AutoBMD™, an AI-powered opportunistic bone density measurement test that works on any CT scan of the chest and abdomen to help doctors quickly identify patients who are having accelerated bone loss and are at risk of cracks
- Companies Partner to Offer Artificial Intelligence-Based Bone Density . . .
FDA cleared HeartLung’s AutoBMD AI as a DEXA-equivalent medical device for opportunistic detection of low bone density in CT scans "We are excited to integrate new AI technologies that enhance patient care across our nationwide practice," said Dr John Simon, founder and CEO of SimonMed Imaging
- Osteoporosis Screening Program – Crown Valley Imaging
Crown Valley Imaging has partnered with HeartLung to offer AutoBMD: a Bone Density Screening report that utilizes existing CT images with no additional scan time or radiation HeartLung AI’s AutoBMD™ is the first FDA-approved, AI-powered, cloud-based tool that enables opportunistic bone mineral density (BMD) measurements from any CT scan of
- SimonMed Imaging, HeartLung Partner to Offer AI-Powered Osteoporosis . . .
HeartLung’s AutoBMD™ AI technology analyzes existing CT scan data to assess bone density, providing a DEXA-equivalent assessment without the need for additional radiation exposure or scanning
- AI-Powered Medical Imaging | Use Case - NVIDIA
AI has the potential to transform healthcare delivery by improving patient outcomes, optimizing operations, and driving innovation AI-enabled imaging solutions are at the forefront of this growth, enhancing image analysis, improving diagnostic accuracy and efficiency, and providing real-time decision-making support to healthcare providers
- AutoBMD - Livelong
HeartLung’s AutoBMD™ is the first and only FDA-approved AI-enabled bone densitometry with “opportunistic screening” indication that is DEXA-equivalent and works both on thoracic and abdominal pelvic CT scans Over 30M women over 65 should have a bone density scan every other year, but less than 7% are getting one
|
|
|